Delivery Order SPE2DB20D7059-SPE2DB25FQNE4
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,401.65 by the Defense Logistics Agency (DLA) on September 2, 2025, with completion targeted for September 3, 2025. The contract, issued under firm fixed price terms with no set-aside designation, calls for the delivery of 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This delivery order is a child contract executed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,186.16 by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is set for July 23, 2025, with performance occurring at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60-tablet packages. This firm fixed-price delivery order, valued at $39,593.14, is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.38 on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for ultimate completion by July 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,065.82 for 60 tablets of Eliquis 5 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement by the Medical Supply Chain, a defense-focused federal agency within the Department of Defense. The award represents a routine...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $12,471.65 for supply of Eliquis 5 mg tablets (60-count units). This competitive, non-set-aside award utilizes firm fixed pricing and is scheduled for completion by July 29, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- On August 7, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,400.64 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- On September 8, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $62,734.71 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order is scheduled for completion by September 9, 2025, and represents a non-competitive, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNE4Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed price delivery order, valued at $4,640.88, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 13, 2025, with performance to occur at the contractor's Conshohocken, Pennsylvania facility. This award demonstrates AmerisourceBergen's critical role in supporting the Defense Health Agency and military healthcare systems through the DLA's Medical Supply Chain. The contractor's IDC vehicle enables flexible ordering of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among the key suppliers competing for continued pharmaceutical distribution to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/12/25 |